Two Sigma Advisers
FBIO icon

Two Sigma Advisers’s Fortress Biotech FBIO Stock Holding History

Two Sigma Advisers’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,250
Closed -$92.4K – 740
2025
Q4 		$92.4K Buy
+25,250
New +$72K ﹤0.01% 2235
2023
Q2 		– Sell
-1,727
Closed -$21.2K – 2467
2023
Q1 		$21.2K Sell
1,727
-120
-6% -$1.43K ﹤0.01% 2512
2022
Q4 		$18.1K Hold
1,847
– – ﹤0.01% 2434
2022
Q3 		$24K Sell
1,847
-86
-4% -$1.29K ﹤0.01% 2433
2022
Q2 		$24K Sell
1,933
-187
-9% -$2.77K ﹤0.01% 2536
2022
Q1 		$43K Sell
2,120
-482
-19% -$13.2K ﹤0.01% 2602
2021
Q4 		$98K Sell
2,602
-15,946
-86% -$711K ﹤0.01% 2412
2021
Q3 		$896K Buy
18,548
+7,946
+75% +$388K ﹤0.01% 1668
2021
Q2 		$568K Sell
10,602
-6,973
-40% -$421K ﹤0.01% 1890
2021
Q1 		$931K Buy
17,575
+240
+1% +$13.5K ﹤0.01% 1690
2020
Q4 		$824K Buy
17,335
+2,227
+15% +$96.5K ﹤0.01% 1660
2020
Q3 		$916K Buy
15,108
+11,520
+321% +$587K ﹤0.01% 1538
2020
Q2 		$144K Buy
+3,588
New +$133K ﹤0.01% 2308

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Advisers's FBIO Position: Q1 2026 in Review

Two Sigma Advisers sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 25,250 shares — an estimated $92.4K sold.

Two Sigma Advisers first reported a position in FBIO in Q2 2020 and held it in 13 quarters. The position peaked at $931K in Q1 2021. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Two Sigma Advisers reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 25,250 Fortress Biotech shares in Q1 2026, an estimated $92.4K.
  • Two Sigma Advisers first reported a position in Fortress Biotech in Q2 2020 and held it in 13 quarters.
  • Two Sigma Advisers's Fortress Biotech position peaked at $931K in Q1 2021.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.